Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients

Resmi Ravindran, Viswanathan V Krishnan, Azra Khanum, Paul A Luciw, Imran H. Khana

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Host immune responses to Mycobacterium tuberculosis are generally able to contain infection and maintain a delicate balance between protection and immunopathology. A shift in this balance appears to underlie active disease observed in about 10% of infected individuals. Effects of local inflammation, combined with anti-M. tuberculosis systemic immune responses, are directly detectable in peripheral circulation, without ex vivo stimulation of blood cells or biopsy of the affected organs. We studied plasma immunomodulator and antibody biomarkers in patients with active pulmonary tuberculosis (TB) by a combination of multiplex microbead immunoassays and computational tools for data analysis. Plasma profiles of 10 immunomodulators and antibodies against eight M. tuberculosis antigens (previously reported by us) were examined in active pulmonary TB patients in a country where TB is endemic, Pakistan. Multiplex analyses were performed on samples from apparently healthy individuals without active TB from the same community as the TB patients to establish the assay baselines for all analytes. Over 3,000 data points were collected from patients (n=135) and controls (n=37). The data were analyzed by multivariate and computer-assisted cluster analyses to reveal patterns of plasma immunomodulators and antibodies. This study shows plasma profiles that in most patients represented either strong antibody or strong immunomodulator biomarkers. Profiling of a combination of both immunomodulators and antibodies described here may be valuable for the analysis of host immune responses in active TB in countries where the disease is endemic.

Original languageEnglish (US)
Pages (from-to)1283-1290
Number of pages8
JournalClinical and Vaccine Immunology
Volume20
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Immunologic Factors
Tuberculosis
Plasmas
Antibodies
Biomarkers
Pulmonary Tuberculosis
Mycobacterium tuberculosis
Active Immunity
Endemic Diseases
Biopsy
Pakistan
Microspheres
Immunoassay
Cluster Analysis
Assays
Blood Cells
Blood
Cells
Inflammation
Antigens

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients. / Ravindran, Resmi; Krishnan, Viswanathan V; Khanum, Azra; Luciw, Paul A; Khana, Imran H.

In: Clinical and Vaccine Immunology, Vol. 20, No. 8, 08.2013, p. 1283-1290.

Research output: Contribution to journalArticle

@article{6d5905d97fa640db9c5bb17cdc07e618,
title = "Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients",
abstract = "Host immune responses to Mycobacterium tuberculosis are generally able to contain infection and maintain a delicate balance between protection and immunopathology. A shift in this balance appears to underlie active disease observed in about 10{\%} of infected individuals. Effects of local inflammation, combined with anti-M. tuberculosis systemic immune responses, are directly detectable in peripheral circulation, without ex vivo stimulation of blood cells or biopsy of the affected organs. We studied plasma immunomodulator and antibody biomarkers in patients with active pulmonary tuberculosis (TB) by a combination of multiplex microbead immunoassays and computational tools for data analysis. Plasma profiles of 10 immunomodulators and antibodies against eight M. tuberculosis antigens (previously reported by us) were examined in active pulmonary TB patients in a country where TB is endemic, Pakistan. Multiplex analyses were performed on samples from apparently healthy individuals without active TB from the same community as the TB patients to establish the assay baselines for all analytes. Over 3,000 data points were collected from patients (n=135) and controls (n=37). The data were analyzed by multivariate and computer-assisted cluster analyses to reveal patterns of plasma immunomodulators and antibodies. This study shows plasma profiles that in most patients represented either strong antibody or strong immunomodulator biomarkers. Profiling of a combination of both immunomodulators and antibodies described here may be valuable for the analysis of host immune responses in active TB in countries where the disease is endemic.",
author = "Resmi Ravindran and Krishnan, {Viswanathan V} and Azra Khanum and Luciw, {Paul A} and Khana, {Imran H.}",
year = "2013",
month = "8",
doi = "10.1128/CVI.00213-13",
language = "English (US)",
volume = "20",
pages = "1283--1290",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients

AU - Ravindran, Resmi

AU - Krishnan, Viswanathan V

AU - Khanum, Azra

AU - Luciw, Paul A

AU - Khana, Imran H.

PY - 2013/8

Y1 - 2013/8

N2 - Host immune responses to Mycobacterium tuberculosis are generally able to contain infection and maintain a delicate balance between protection and immunopathology. A shift in this balance appears to underlie active disease observed in about 10% of infected individuals. Effects of local inflammation, combined with anti-M. tuberculosis systemic immune responses, are directly detectable in peripheral circulation, without ex vivo stimulation of blood cells or biopsy of the affected organs. We studied plasma immunomodulator and antibody biomarkers in patients with active pulmonary tuberculosis (TB) by a combination of multiplex microbead immunoassays and computational tools for data analysis. Plasma profiles of 10 immunomodulators and antibodies against eight M. tuberculosis antigens (previously reported by us) were examined in active pulmonary TB patients in a country where TB is endemic, Pakistan. Multiplex analyses were performed on samples from apparently healthy individuals without active TB from the same community as the TB patients to establish the assay baselines for all analytes. Over 3,000 data points were collected from patients (n=135) and controls (n=37). The data were analyzed by multivariate and computer-assisted cluster analyses to reveal patterns of plasma immunomodulators and antibodies. This study shows plasma profiles that in most patients represented either strong antibody or strong immunomodulator biomarkers. Profiling of a combination of both immunomodulators and antibodies described here may be valuable for the analysis of host immune responses in active TB in countries where the disease is endemic.

AB - Host immune responses to Mycobacterium tuberculosis are generally able to contain infection and maintain a delicate balance between protection and immunopathology. A shift in this balance appears to underlie active disease observed in about 10% of infected individuals. Effects of local inflammation, combined with anti-M. tuberculosis systemic immune responses, are directly detectable in peripheral circulation, without ex vivo stimulation of blood cells or biopsy of the affected organs. We studied plasma immunomodulator and antibody biomarkers in patients with active pulmonary tuberculosis (TB) by a combination of multiplex microbead immunoassays and computational tools for data analysis. Plasma profiles of 10 immunomodulators and antibodies against eight M. tuberculosis antigens (previously reported by us) were examined in active pulmonary TB patients in a country where TB is endemic, Pakistan. Multiplex analyses were performed on samples from apparently healthy individuals without active TB from the same community as the TB patients to establish the assay baselines for all analytes. Over 3,000 data points were collected from patients (n=135) and controls (n=37). The data were analyzed by multivariate and computer-assisted cluster analyses to reveal patterns of plasma immunomodulators and antibodies. This study shows plasma profiles that in most patients represented either strong antibody or strong immunomodulator biomarkers. Profiling of a combination of both immunomodulators and antibodies described here may be valuable for the analysis of host immune responses in active TB in countries where the disease is endemic.

UR - http://www.scopus.com/inward/record.url?scp=84880883164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880883164&partnerID=8YFLogxK

U2 - 10.1128/CVI.00213-13

DO - 10.1128/CVI.00213-13

M3 - Article

C2 - 23761664

AN - SCOPUS:84880883164

VL - 20

SP - 1283

EP - 1290

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 8

ER -